Valneva: Encephalitis, Japanese trials

The registry lists 17 Encephalitis, Japanese studies with Valneva as lead sponsor. 0 are open to participants now and 14 have results posted.

Phase 1 1Phase 3 13Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic CountryCompletedNCT01296360Phase 3Results posted
• Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-StudyCompletedNCT01246479Phase 3Results posted
• Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesCompletedNCT01047839Phase 3Results posted
• Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric PopulationCompletedNCT01041573Phase 3Results posted
• Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post FillingCompletedNCT00776230Phase 3Results posted
• Safety and Tolerability of the Japanese Encephalitis Vaccine IC51CompletedNCT00605085Phase 3Results posted
• Immunogenicity Study of the Japanese Encephalitis Vaccine IC51CompletedNCT00604708Phase 3Results posted
• Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440CompletedNCT00596271Phase 3Results posted
• Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51CompletedNCT00596102Results posted
• Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51CompletedNCT00595790Phase 3Results posted
• Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51CompletedNCT00595465Phase 3Results posted
• Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51CompletedNCT00595309Phase 3Results posted
• Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51CompletedNCT00595270Phase 3Results posted
• Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51CompletedNCT00594958Phase 3Results posted
• Immune Response in IXIARO Batch JEV09L37 Recipients Before and After RevaccinationWithdrawnNCT01559831Phase 1
• Safety Surveillance After Immunization With IXIAROCompletedNCT01335412
• This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly PopulationCompletedNCT01158599Phase 4